| NCT00112658 |
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer |
View |
| NCT01707758 |
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence |
View |
| NCT02845258 |
Treatment of Pancreatic Pseudocysts by Endoscopic Ultrasound-guided Drainage |
View |
| NCT04117958 |
Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers |
View |
| NCT06259058 |
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer |
View |
| NCT00909558 |
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer |
View |
| NCT03856658 |
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases |
View |
| NCT05489458 |
Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy |
View |
| NCT04595058 |
LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent |
View |
| NCT03267173 |
Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. |
View |
| NCT04239573 |
Comparing Two Methods to Follow Patients With Pancreatic Cysts |
View |
| NCT02311439 |
Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas |
View |
| NCT07034339 |
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution |
View |
| NCT02158039 |
Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms |
View |
| NCT03104439 |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer |
View |
| NCT05703139 |
Efficacy of the Triangle Operation on Clinical Outcomes in Patients With Pancreatic Cancer |
View |
| NCT01959139 |
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer |
View |
| NCT04683939 |
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors |
View |
| NCT04634539 |
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer |
View |
| NCT04977596 |
Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer |
View |
| NCT04217096 |
Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in Advanced Pancreatic Cancer Patients |
View |
| NCT06364696 |
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors |
View |
| NCT01104116 |
Use of PET Imaging to Distinguish Malignant From Benign IPMN |
View |
| NCT01167816 |
Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer |
View |
| NCT02395016 |
A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer |
View |
